首页> 外文期刊>Acta crystallographica. Section C, Structural chemistry. >Preparation and structural analysis of (±)-cis-ethyl 2-sulfanylidenedeca-hydro-1,6-naphthyridine-6-carboxyl-ate and (±)-trans-ethyl 2-oxoocta-hydro-1H-pyrrolo[3,2-c]pyridine-5-carboxylate
【24h】

Preparation and structural analysis of (±)-cis-ethyl 2-sulfanylidenedeca-hydro-1,6-naphthyridine-6-carboxyl-ate and (±)-trans-ethyl 2-oxoocta-hydro-1H-pyrrolo[3,2-c]pyridine-5-carboxylate

机译:(±)-顺乙基2-磺酰基二烯基-hydro-1,6-萘啶-6-羧酸盐和(±)-反乙基2-氧代辛基-hydro-1H-吡咯[3,2]的制备及结构分析-c] -5-羧酸吡啶

获取原文
获取原文并翻译 | 示例
           

摘要

The chemical scaffolds (1-1), (1-2), (2-1) and (2-2) themselves appear underrepresented in the medicinal chemical literature and therefore warrant further investigation. It had been reported that compound (3) (Scheme 2) targets the bradykinin receptor (Hu et al., 2005), which is a member of the GPCR family and has a key role as a pro-inflammatory mediator (Hall, 1997; Yogi et al., 2009). Compounds (4a) and (4b) (Scheme 2) act as serotonin 5HT receptor ligands (Fevig et al., 2006). The serotonin receptors are found in the central and peripheral nervous system and mediate both excitatory and inhibitory neurotransmission (Wang et al., 2013; Wacker et al., 2013; Raote et al., 2007).
机译:化学支架(1-1),(1-2),(2-1)和(2-2)本身在药物化学文献中的代表性不足,因此有待进一步研究。据报道,化合物(3)(方案2)靶向缓激肽受体(Hu等,2005),该缓激肽受体是GPCR家族的成员,并且具有促炎性介质的关键作用(Hall,1997; Hall,1997; Hall,1997)。 Yogi等,2009)。化合物(4a)和(4b)(方案2)充当5-羟色胺5HT受体配体(Fevig等,2006)。血清素受体存在于中枢神经系统和周围神经系统中,介导兴奋性和抑制性神经传递(Wang等,2013; Wacker等,2013; Raote等,2007)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号